YR

Yogita Rishi

Active Director Director DIN 09702487
DIN 09702487 First appointment Sep 2022 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2022
Shareholding value •••• Premium profile

About Yogita Rishi

Data last updated:

Yogita Rishi is a Director at Medzul Health Private Limited (since 2022). The company operates in Healthcare. Medzul Health Private Limited reported revenue of ₹49.2 Lakh (FY 2024).

DIN 09702487
Primary Designation Director
Industry Healthcare
First Appointment 05 Sep 2022
Oldest Company Age 11 yrs
Largest company Medzul Health Private Limited · ₹49.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medzul Health Private Limited U85100DL2015PTC276937
Director05 Sep 20222015₹49.2 Lakh (FY 2024)Active

Board colleagues of Yogita Rishi

Directorship timeline

Open interactive timeline →
Medzul Health Private Limited
Premium access

Shareholding and investment profile for Yogita Rishi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogita Rishi

Yogita Rishi currently holds 1 directorship: Medzul Health Private Limited (Director, since 05 Sep 2022, revenue ₹49.2 Lakh (FY 2024)).

Yogita Rishi was first appointed on 05 Sep 2022 as Director at Medzul Health Private Limited.

The current boards of Yogita Rishi's companies include Kiran Sharma (Medzul Health Private Limited), Naranzul Urjinlkham (Medzul Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available